A

Abcuro

1 follower

Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class ant... Read more

Industries

Employees

11-50

Links

Org chart

Alex Martin's profile picture
Alex Martin
Chief Executive Officer
Profile photo

Alex Martin

Collapse
H. Jeffrey Wilkins, MD's profile picture
H. Jeffrey Wilkins, MD
Chief Medical Officer
Ricky Motschwiller's profile picture
Ricky Motschwiller
Vice President Finance
Dave Borbas' profile picture
Dave Borbas
Research VP, Head of Data Management
Mike Gress' profile picture
Mike Gress
VP, Clinical Development & Head, Clinical Trial Management
Daniel Mansuri's profile picture
Daniel Mansuri
Head, Corporate Development
Kristin Lurk
Senior Director, Program Management
Donna Byrne
Director, Clinical Operations
Bill Yates
VP, Information Technology
Jeff Geary
Director, Human Resources
  1. Something went wrong loading the org chart, please refresh the page.